Bay Area's Principia Biopharma Scores $765M MS Licensing Deal With Drug Giant Sanofi Post author:Sam Post published:November 8, 2017 Post category:BioPharma Sanofi will write a check for $40 million upfront. Source: BioSpace You Might Also Like Endologix Announces Positive Clinical Results From The LEOPARD Clinical Study August 16, 2017 What You Need to Know About Merck & Co.'s Fearless CEO August 14, 2017 MabVax Therapeutics Board Of Directors Authorizes The Company To Explore Strategic Alternatives July 23, 2017
MabVax Therapeutics Board Of Directors Authorizes The Company To Explore Strategic Alternatives July 23, 2017